Lataa...
Evolving immunotherapeutic strategies in bladder and renal cancer
For patients with urological cancers, immunotherapy is currently a treatment option for metastatic renal cell carcinoma, and those with "high risk" superficial bladder cancers. In this review, our current understanding of tumour immune escape is discussed. The principles and role of curren...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Group
2004
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1743027/ https://ncbi.nlm.nih.gov/pubmed/15192163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/pgmj.2003.013508 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|